title: Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.
abstract: OBJECTIVE
  To assess blood pressure outcome in patients with primary aldosteronism, who were operated on the basis of a unilateral adenoma detected by computed tomography or a lateralized aldosterone hypersecretion detected by adrenal venous sampling, and to analyze the hormonal and nonhormonal factors associated with the outcome.
  
  
  METHODS
  A retrospective study of 168 patients with primary aldosteronism undergoing surgery: 109 patients with a unilateral adenoma detected by computed tomography and 59 without a unilateral adenoma who underwent surgery because of an aldosterone to cortisol ratio at least five times higher on the dominant side than on the nondominant side.
  
  
  RESULTS
  Patients with a unilateral adenoma were more likely to be women, had a shorter history of hypertension and had lower blood pressure levels and treatment scores than patients without a unilateral adenoma. The mean systolic blood pressures of patients with and without unilateral adenomas at follow-up were 133 +/- 16 and 137 +/- 16 mmHg, respectively. Hypertension cure or improvement was observed in 77% (95% confidence interval 69-85%) and 68% (95% confidence interval 56-80%) of patients, respectively. Using a linear regression model, baseline urinary aldosterone was positively associated, and baseline serum potassium was negatively associated, with decrease in systolic blood pressure.
  
  
  CONCLUSIONS
  Adrenalectomy improves blood pressure control in patients with primary aldosteronism operated on the basis of either unilateral adenoma detected by computed tomography or a lateralized aldosterone hypersecretion. A high urinary aldosterone excretion and a low serum potassium level predict a more favorable outcome of surgery.
authors.affiliation: AP-HP, Hôpital Européen Georges Pompidou, Hypertension unit, Faculté de Médecine, Université Paris Descartes, Paris, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Letavernier
authors.forename: Séverine
authors.initials: S
authors.lastname: Peyrard
authors.forename: Laurence
authors.initials: L
authors.lastname: Amar
authors.forename: Franck
authors.initials: F
authors.lastname: Zinzindohoué
authors.forename: Béatrice
authors.initials: B
authors.lastname: Fiquet
authors.forename: Pierre-François
authors.initials: PF
authors.lastname: Plouin
mesh_terms: D000236:Adenoma / Q000150:complications / Q000601:surgery*; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000601:surgery*; D000315:Adrenalectomy; D000328:Adult; D000450:Aldosterone / Q000652:urine; D001794:Blood Pressure; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006929:Hyperaldosteronism / Q000209:etiology / Q000601:surgery*; D006973:Hypertension / Q000175:diagnosis / Q000209:etiology*; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011188:Potassium / Q000097:blood; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000450:Aldosterone; D011188:Potassium